UK Industry Urges Labour To Go Further With Life Sciences Plan
BGMA Urges Consideration Of Generic Competition, Biosimilar Savings And IP Costs
A life sciences plan unveiled by the UK’s Labour party – which polls indicate is likely to take power after the country’s imminent general election – could “go further in considering the role of off-patent medicines,” the BGMA believes.
